CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia-reperfusion injury

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 8, 2015, Pages 1825-1835

  Cai, Wen Feng ^a   Kang, Kai ^a   Huang, Wei ^a   Liang, Jia Liang ^a   Feng, Yu Liang ^a   Liu, Guan Sheng ^a   Chang, De Hua ^a   Wen, Zhi Li ^a   Paul, Christian ^a   Xu, Meifeng ^a   Millard, Ronald W ^a   Wang, Yigang ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiomyocytes; CXCR4 overexpression; Ischaemia reperfusion injury; Mitochondria; STAT3

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM; CHEMOKINE RECEPTOR CXCR4; HYDROGEN PEROXIDE; STAT3 PROTEIN; CARDIOTONIC AGENT;

ADENOVIRUS INFECTION; ADULT; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; GENE OVEREXPRESSION; HEART MUSCLE CELL; HYPOXIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; WESTERN BLOTTING; ADENOVIRIDAE; ANIMAL; CARDIAC MUSCLE CELL; CELL DEATH; CELL HYPOXIA; CYTOSOL; DRUG EFFECTS; HEART MITOCHONDRION; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; RATTUS;

ADENOVIRIDAE; ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CELL DEATH; CELL HYPOXIA; CYTOSOL; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; STAT3 TRANSCRIPTION FACTOR;

EID: 84938082304     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12554     Document Type: Article

References (30)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007; 357: 1121-35.
2. Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013; 123: 92-100.
3. Ovize M, Baxter GF, Di Lisa F, etal. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010; 87: 406-23.
4. Wu B, Chien EY, Mol CD, etal. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010; 330: 1066-71.
5. Duchesneau P, Gallagher E, Walcheck B, etal. Up-regulation of leukocyte CXCR4 expression by sulfatide: an L-selectin-dependent pathway on CD4+ T cells. Eur J Immunol. 2007; 37: 2949-60.
6. LaRocca TJ, Schwarzkopf M, Altman P, etal. β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. J Cardiovasc Pharmacol. 2010; 56: 548-59.
7. Pyo RT, Sui J, Dhume A, etal. CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol. 2006; 41: 834-44.
8. Damås JK, Eiken HG, Oie E, etal. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res. 2000; 47: 778-87.
9. Chen J, Chemaly E, Liang L, etal. Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury. Am J Pathol. 2010; 176: 1705-15.
10. Huang C, Gu H, Zhang W, etal. SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol. 2011; 301: H1496-505.
11. Larocca TJ, Jeong D, Kohlbrenner E, etal. CXCR4 gene transfer prevents pressure overload induced heart failure. J Mol Cell Cardiol. 2012; 53: 223-32.
12. Walters AM, Porter GA Jr, Brookes PS. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res. 2012; 111: 1222-36.
13. Zhang D, Fan GC, Zhou X, etal. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol. 2008; 44: 281-92.
14. Cai WF, Pritchard T, Florea S, etal. Ablation of junctin or triadin is associated with increased cardiac injury following ischaemia/reperfusion. Cardiovasc Res. 2012; 94: 333-41.
15. Lam CK, Zhao W, Cai W, etal. Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90. Circ Res. 2013; 112: 79-89.
16. Chen G, Zhou X, Florea S, etal. Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis. Basic Res Cardiol. 2010; 105: 573-81.
17. de Groot H, Rauen U. Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplant Proc. 2007; 39: 481-4.
18. Liang J, Huang W, Yu X, etal. Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)). PLoS ONE. 2012; 7: e46158.
19. Davidson SM, Selvaraj P, He D, etal. Remote ischemic preconditioning involves signaling through the SDF-1α/CXCR4 signaling axis. Basic Res Cardiol. 2013; 108: 377.
20. Przyklenk K. 'Going out on a limb': SDF-1α/CXCR4 signaling as a mechanism of remote ischemic preconditioning? Basic Res Cardiol. 2013; 108: 382.
21. Kolwicz SC Jr, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res. 2013; 113: 603-16.
22. Jassem W, Heaton ND. The role of mitochondria in ischemia/reperfusion injury in organ transplantation. Kidney Int. 2004; 66: 514-7.
23. Müller J, Gorressen S, Grandoch M, etal. Interleukin-6-dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction. Basic Res Cardiol. 2014; 109: 440.
24. Tammineni P, Anugula C, Mohammed F, etal. The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J Biol Chem. 2013; 288: 4723-32.
25. Wegrzyn J, Potla R, Chwae YJ, etal. Function of mitochondrial Stat3 in cellular respiration. Science. 2009; 323: 793-7.
26. Boengler K, Hilfiker-Kleiner D, Heusch G, etal. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol. 2010; 105: 771-85.
27. Heusch G, Musiolik J, Gedik N, etal. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res. 2011; 109: 1302-8.
28. Boengler K, Ungefug E, Heusch G, etal. The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation. Curr Pharm Des. 2013; 19: 6890-5.
29. Boengler K, Buechert A, Heinen Y, etal. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res. 2008; 102: 131-5.
30. Hajjar RJ, Zsebo K, Deckelbaum L, etal. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J Card Fail. 2008; 14: 355-67.